Myths and misconceptions about childhood constipation

Shaman Rajindrajith1, Niranga Manjuri Devanarayana2, Nikhil Thapar3

  • 1Department of Pediatrics, Faculty of Medicine, University of Colombo, Colombo, 00800, Sri Lanka. shamanrajindrajith4@gmail.com.

Insights

Childhood constipation affects 9.5% of children globally, often due to functional issues, not organic ones. Effective management requires challenging myths and prioritizing laxatives over ineffective strategies.

Area of Science:

  • Pediatrics
  • Gastroenterology

Background:

  • Childhood constipation is a prevalent global issue with significant healthcare costs.
  • Myths and misconceptions contribute to ineffective management, leading to psychological and bowel damage.

Purpose of the Study:

  • To challenge common myths and misconceptions surrounding childhood constipation.
  • To encourage a re-evaluation of established concepts that hinder effective treatment.

Main Methods:

  • Literature review to explore existing evidence on childhood constipation.
  • Analysis of common beliefs regarding etiology, pathophysiology, and management.

Main Results:

  • Functional constipation is far more common than organic causes; investigations are often unhelpful.
  • Non-pharmacological interventions are frequently ineffective; laxatives are the primary treatment.

Conclusions:

  • Myths lead to incorrect diagnoses, ineffective treatments, and unnecessary healthcare spending.
  • Poorly managed constipation causes significant psychological distress and long-term bowel dysfunction.

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
328
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
275
Feces Formation and Defecation01:26

Feces Formation and Defecation

After spending 3 to 10 hours in the large intestine, chyme loses a lot of water and becomes feces, the final product of digestion. Feces consist of undigested dietary fiber such as cellulose, mucus, sloughed-off epithelial cells, and microbes. The descending and sigmoid colon stores feces and uses haustral contractions to dry it out but retains enough water to give it a semi-solid texture.
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
1.2K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
346
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
216
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
282